AWWA ACE68672 PDF

AWWA ACE68672 PDF

Name:
AWWA ACE68672 PDF

Published Date:
11/01/2008

Status:
Active

Description:

Demonstration of Bromate Mitigation Using Carbon Dioxide and the Innovative Chlorine/Ammonia Process

Publisher:
American Water Works Association

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Russian version):
200 business days

SKU:

Choose Document Language:
$7.2
Need Help?
This powerpoint presentation begins by presenting background information on the bromate mitigation project, including: plant operation prior to study; bromate formation; and, an initial study done in 2006-2007. Bromate mitigation objective included: demonstrate Bromate Mitigation Strategies at full-scale level; pH depression via CO<sub>2</sub> addition; and, Cl<sub>2</sub>/NH<sub>3</sub> addition. The Bromate Mitigation Testing Layout is presented, along with demonstration testing, preliminary CO<sub>2</sub> data analysis CO<sub>2</sub> testing results (pH = 7.2) and (O3/TOC = 1.0), CO<sub>2</sub> dosing, observations of CO<sub>2</sub> testing, Cl<sub>2</sub>/NH<sub>3</sub> additional testing, status and results (bench-scale), and TTHM formation (Bench-Scale). Includes figures.
Edition : Vol. - No.
File Size : 1 file , 3 MB
Note : This product is unavailable in Ukraine, Russia, Belarus
Number of Pages : 26
Published : 11/01/2008

History


Related products

AWWA ACE68640
Published Date: 11/01/2008
Disinfection Alternatives for Water Distribution Systems Following Biological Contamination
$7.2
AWWA ACE69064
Published Date: 11/01/2008
Novel Strategies for the Characterization of Mixed-Oxidant Solutions for Drinking Water Disinfection
$7.2
AWWA ACE68902
Published Date: 11/01/2008
Toho Water Authority: An Example of Consolidation for Regional Water Supply Development
$7.2
AWWA ACE68662
Published Date: 11/01/2008
Washington's Water Use Efficiency Rule: Meters, 10% Leakage Standard, and Much More
$7.2

Best-Selling Products

Alzheimer's Disease Report
Published Date: 12/01/2018
$2398.5
Cystic Fibrosis Disease Report
Published Date: 04/01/2019
$2398.5
Multiple Sclerosis Disease Report
Published Date: 12/01/2018
$2398.5
Non-Alcoholic Steatohepatitis Disease Report
Published Date: 12/01/2018
$2398.5
Non-Hodgkin's Lymphoma Disease Report
Published Date: 12/01/2018
$2398.5